Idiopathic/heritable pulmonary arterial hypertension

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Idiopathic/heritable pulmonary arterial hypertension.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Idiopathic/heritable pulmonary arterial hypertension.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Sildenafil

(SILDENAFIL POWDER,)Orphan drug

Camber Pharmaceuticals, Inc.

12.1 Mechanism of Action Sildenafil is an inhibitor of cGMP specific PDE-5 in the smooth muscle of the pulmonary vasculature, where PDE-5 is responsib...

Approved Jan 2023FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Idiopathic/heritable pulmonary arterial hypertension.
Search all trials →
Search clinical trials for Idiopathic/heritable pulmonary arterial hypertension

Recent News & Research

No recent news articles indexed yet for Idiopathic/heritable pulmonary arterial hypertension.
Search PubMed for Idiopathic/heritable pulmonary arterial hypertension

Browse all Idiopathic/heritable pulmonary arterial hypertension news →

Specialist Network

Top 6 by expertise

View all Idiopathic/heritable pulmonary arterial hypertension specialists →

Quick Actions